IDH1 and nasopharyngeal carcinoma: Notably, PTBP1 targeting exerted much stronger antitumor effects in IDH1-WT iPSC-NPC than in IDH1-mut iPSC-NPC (Figure 9E and Supplemental Figure 7E).